When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TORC - FDA on board with design of late-stage studies of resTORbio's RTB101
resTORbio Inc.
ResTORbio (TORC+2.3%) is on go to launch two Phase 3 clinical trials evaluating lead candidate RTB101 for preventing respiratory tract infections (RTIs) in the elderly.
More news on: resTORbio, Inc., Healthcare stocks news,